Cellular Health Screening/Health Testing Market Overview
The cellular health screening/health testing market is expected to grow at 9.9% CAGR from 2020 to 2029. It is expected to reach above USD 5.4 billion by 2029 from USD 2.3 billion in 2020.
Cellular health screening, sometimes referred to as health testing, is a thorough evaluation of a person's general health that looks at cellular function and looks for imbalances and possible health hazards. Since cells in the body serve as the building blocks of tissues, organs, and systems, this sort of screening offers a more thorough study than conventional medical tests.
[caption id="attachment_29526" align="aligncenter" width="1920"]
Cellular Health Screening/Health Testing Market | Exactitude Consultancy[/caption]
A number of tests are performed as part of a cellular health screening to assess the body's capacity for repair and regeneration as well as cell function. These examinations could involve genetic testing, urine analysis, and blood work. To discover potential health problems like inflammation, oxidative stress, and vitamin shortages, the data are then examined. With this knowledge, medical professionals can collaborate with patients to create individualized treatment regimens that will correct any imbalances and improve general health and wellness.
The rising need for individualized and preventive healthcare is one of the main motivators. People are increasingly looking for strategies to maintain their health and stop the development of diseases as a result of the growth in chronic diseases and the high expense of healthcare. Through the identification of potential health hazards before they develop into more serious illnesses, cellular health screening and testing provide a proactive approach to treatment. This enables people to maintain their health and well-being by taking preventive actions like lifestyle adjustments or early medical intervention.
It is now possible to examine cellular health and identify disorders at the cellular level thanks to the development of new technologies like next-generation sequencing, liquid biopsy, and microfluidics. In comparison to conventional diagnostic techniques, these technologies provide improved accuracy and sensitivity, enabling earlier disease identification and more accurate diagnosis. As a result, cellular health testing and screening are becoming more widely available and reasonably priced, and they are anticipated to play a bigger part in healthcare in the future.
The cellular health screening/ health testing market is a rapidly growing industry that presents significant opportunities for growth and innovation. As consumers become more interested in taking control of their health, the demand for affordable and accessible health testing services is increasing. This has led to the development of new technologies and services, such as at-home testing kits and mobile health clinics, which are making it easier for individuals to monitor their health and prevent disease. With the aging population and increasing focus on preventive healthcare, this market is poised for continued growth.
The high cost of these tests, which prevents certain people from accessing them, is one of the main barriers in the market for cellular health screening/health testing. Furthermore, there is a lack of standardization in testing procedures, which can provide inconsistent results and make it challenging for healthcare professionals to decide what patients need. The regulatory environment is also complicated and might present difficulties for businesses looking to sell innovative testing technology.
The COVID-19 pandemic has significantly impacted the cellular health screening/health testing market as it has caused a disruption in the supply chain and limited the availability of testing services. The market has seen a decline in demand due to reduced healthcare visits and financial constraints among consumers. However, the market is expected to recover as vaccination rates increase and the healthcare industry adapts to the new normal.
ATTRIBUTE |
DETAILS |
Study period |
2020-2029 |
Base year |
2021 |
Estimated year |
2022 |
Forecasted year |
2022-2029 |
Historical period |
2018-2020 |
Unit |
Value (USD Billion) |
Segmentation |
By Type of Test, By Sample Type, By End User, By Region |
By Type of Test |
- Telomere Testing
- Oxidative Stress Testing
- Inflammation Testing
- Heavy Metal
|
By Sample Type |
|
By End User |
- Individuals
- Hospitals and Clinics
- Research Industries
|
By Region |
- North America
- Asia Pacific
- Europe
- South America
- Middle East Asia & Africa
|
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
- TELOMERE TESTING
- OXIDATIVE STRESS TESTING
- INFLAMMATION TESTING
- HEAVY METAL
- GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
- BLOOD
- URINE
- GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
- INDIVIDUALS
- HOSPITALS AND CLINICS
- RESEARCH INDUSTRIES
- GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY REGION (USD BILLION) 2020-2029
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, TYPE OF TESTS OFFERED, RECENT DEVELOPMENTS)
- INSIDE TRACKER
- THORNE
- VIOME
- WELLNESSFX
- EVERLY WELL
- NOURISH BALANCE THRIVE
- HEALTH SNAP
- BIO AGE LABS
- ATLAS BIOMED
- BAZE
- BIOMARKER STRATEGIES
- CENEGENICS
- CYREX LABORATORIES*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 2 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 3 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 4 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY REGION (USD BILLION) 2020-2029
TABLE 5 NORTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 6 NORTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 7 NORTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 8 NORTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 9 US CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 10 US CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 11 US CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 12 CANADA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 13 CANADA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 14 CANADA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 15 MEXICO CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 16 MEXICO CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 17 MEXICO CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 18 SOUTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 19 SOUTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 20 SOUTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 21 SOUTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 22 BRAZIL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 23 BRAZIL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 24 BRAZIL CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 25 ARGENTINA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 26 ARGENTINA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 27 ARGENTINA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 28 COLOMBIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 29 COLOMBIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 30 COLOMBIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 31 REST OF SOUTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 32 REST OF SOUTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 33 REST OF SOUTH AMERICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 34 ASIA-PACIFIC CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 35 ASIA-PACIFIC CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 36 ASIA-PACIFIC CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 37 ASIA-PACIFIC CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 38 INDIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 39 INDIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 40 INDIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 41 CHINA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 42 CHINA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 43 CHINA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 44 JAPAN CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 45 JAPAN CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 46 JAPAN CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 47 SOUTH KOREA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 48 SOUTH KOREA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 49 SOUTH KOREA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 50 AUSTRALIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 51 AUSTRALIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 52 AUSTRALIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 53 SOUTH-EAST ASIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 54 SOUTH-EAST ASIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 55 SOUTH-EAST ASIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 56 REST OF ASIA PACIFIC CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 57 REST OF ASIA PACIFIC CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 58 REST OF ASIA PACIFIC CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 59 EUROPE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 60 EUROPE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 61 EUROPE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 62 EUROPE C CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 63 GERMANY CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 64 GERMANY CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 65 GERMANY CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 66 UK CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 67 UK CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 68 UK CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 69 FRANCE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 70 FRANCE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 71 FRANCE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 72 ITALY CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 73 ITALY CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 74 ITALY CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 75 SPAIN CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 76 SPAIN CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 77 SPAIN CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 78 RUSSIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 79 RUSSIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 80 RUSSIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 81 REST OF EUROPE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 82 REST OF EUROPE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 83 REST OF EUROPE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 84 MIDDLE EAST AND AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 85 MIDDLE EAST AND AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 86 MIDDLE EAST AND AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 87 MIDDLE EAST AND AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 88 UAE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 89 UAE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 90 UAE CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 91 SAUDI ARABIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 92 SAUDI ARABIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 93 SAUDI ARABIA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 94 SOUTH AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 95 SOUTH AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 96 SOUTH AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
TABLE 97 REST OF MIDDLE EAST AND AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY TYPE OF TEST (USD BILLION) 2020-2029
TABLE 98 REST OF MIDDLE EAST AND AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 99 REST OF MIDDLE EAST AND AFRICA CELLULAR HEALTH SCREENING/HEALTH TESTING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2029
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY TYPE OF TEST, USD BILLION, 2020-2029
FIGURE 9 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY SAMPLE TYPE, USD BILLION, 2020-2029
FIGURE 10 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY END USER, USD BILLION, 2020-2029
FIGURE 11 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY REGION, USD BILLION, 2020-2029
FIGURE 12 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY TYPE OF TEST, USD BILLION, 2021
FIGURE 13 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY SAMPLE TYPE, USD BILLION, 2021
FIGURE 14 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY END USER, USD BILLION, 2021
FIGURE 15 GLOBAL CELLULAR HEALTH SCREENING/HEALTH TESTING BY REGION, USD BILLION, 2021
FIGURE 16 PORTER’S FIVE FORCES MODEL
FIGURE 17 MARKET SHARE ANALYSIS
FIGURE 18 INSIDE TRACKER: COMPANY SNAPSHOT
FIGURE 19 THORNE: COMPANY SNAPSHOT
FIGURE 20 VIOME: COMPANY SNAPSHOT
FIGURE 21 WELLNESS FX: COMPANY SNAPSHOT
FIGURE 22 EVERLY WELL: COMPANY SNAPSHOT
FIGURE 23 NOURISH BALANCE THRIVE: COMPANY SNAPSHOT
FIGURE 24 HEALTH SNAP: COMPANY SNAPSHOT
FIGURE 25 BIO AGE LABS: COMPANY SNAPSHOT
FIGURE 26 ATLAS BIOMED: COMPANY SNAPSHOT
FIGURE 27 BAZE: COMPANY SNAPSHOT
FIGURE 28 BIOMARKER STRATEGIES: COMPANY SNAPOSHOT
FIGURE 29 CYREX LABORATORIES: COMPANY SNAPSHOT